Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Zero-based budgeting for families demonstrates collaborative budgeting and shared goals for better financial health.
16,996 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Navitas Semiconductor is pursuing an AI data-center power strategy built around 800V architecture. This move could re...
March's trading session brought a noticeable shift as airline stocks rallied amid easing fuel concerns. This piece br...
BlackRock’s chief executive argues that AI’s biggest impact is on who owns wealth, not just who loses a job. Here’s h...
A single insider sale coincided with a sharp move lower in Sprinklr’s shares, prompting questions about signal versus...
Nvidia’s CEO set a trillion-dollar demand target for its AI chips through 2027, shifting attention to Taiwan Semicond...
Braze stock surged today as the marketing-tech player highlighted AI-driven growth and stronger customer engagement m...
As software shares pull back in 2026, you don’t have to chase chaos. This article identifies one software stock actua...
Avis Budget Group stock surged this week as travel demand picked up and airport bottlenecks nudged customers toward r...
BTIG raises Palo Alto Networks' price target to $216 after channel checks show improving partner feedback. Buy rating...
Kick off your week with a curated list of investing insights. These Monday reads translate market noise into actionab...
Investors are watching Friday’s April payroll report for signs that businesses really starting hire signals a broader...